Burden of itch in ichthyosis: a multicentre study in 94 patients.
Journal
Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037
Informations de publication
Date de publication:
Nov 2019
Nov 2019
Historique:
received:
23
12
2018
accepted:
01
04
2019
pubmed:
8
5
2019
medline:
17
4
2020
entrez:
8
5
2019
Statut:
ppublish
Résumé
From clinical experience, we know that itch is a major concern for many ichthyosis patients. Nonetheless, no previous studies specifically addressed the issue of itch in ichthyosis. The objective of this study was to specifically address the burden of itch and all its dimensions in ichthyosis patients. Ninety-four ichthyosis patients from four different centres were recruited to participate in this cross-sectional, questionnaire-based study. All participants completed the Leuven Itch Scale, a multidimensional self-report instrument that quantifies the frequency, duration, severity, distress, consequences and surface area of itch. Participants included 18 keratinopathic types, 55 autosomal recessive congenital ichthyoses, 11 X-linked recessive ichthyoses (XLRIs), 6 Netherton's ichthyoses, 1 Sjögren-Larsson type, 1 Iocrin ichthyosis and 2 unknown subtypes. Itch occurred in 93% of all patients. In patients with itch, 63% reported that it was often or always present, although most itch episodes were short in duration. Itch, in all its dimensions, was worst in patients with Netherton syndrome. Patients with XLRI had in general a lower itch profile. About half of all ichthyosis patients reported to experience flares during a change in weather, in a hot environment or in stressful situations, whereas a cold environment led to itch in only 26% of patients. The most significant consequences of itching were lesions from scratching, difficulties in falling asleep, bad mood and loss of concentration. Itch is a major concern in patients with ichthyosis, with significant impact on daily life. Research on future treatments should therefore take itch into consideration and itch should be evaluated in clinical studies. Among the studied subgroups, Netherton patients experienced the most severe consequences.
Sections du résumé
BACKGROUND
BACKGROUND
From clinical experience, we know that itch is a major concern for many ichthyosis patients. Nonetheless, no previous studies specifically addressed the issue of itch in ichthyosis.
OBJECTIVE
OBJECTIVE
The objective of this study was to specifically address the burden of itch and all its dimensions in ichthyosis patients.
METHODS
METHODS
Ninety-four ichthyosis patients from four different centres were recruited to participate in this cross-sectional, questionnaire-based study. All participants completed the Leuven Itch Scale, a multidimensional self-report instrument that quantifies the frequency, duration, severity, distress, consequences and surface area of itch.
RESULTS
RESULTS
Participants included 18 keratinopathic types, 55 autosomal recessive congenital ichthyoses, 11 X-linked recessive ichthyoses (XLRIs), 6 Netherton's ichthyoses, 1 Sjögren-Larsson type, 1 Iocrin ichthyosis and 2 unknown subtypes. Itch occurred in 93% of all patients. In patients with itch, 63% reported that it was often or always present, although most itch episodes were short in duration. Itch, in all its dimensions, was worst in patients with Netherton syndrome. Patients with XLRI had in general a lower itch profile. About half of all ichthyosis patients reported to experience flares during a change in weather, in a hot environment or in stressful situations, whereas a cold environment led to itch in only 26% of patients. The most significant consequences of itching were lesions from scratching, difficulties in falling asleep, bad mood and loss of concentration.
CONCLUSIONS
CONCLUSIONS
Itch is a major concern in patients with ichthyosis, with significant impact on daily life. Research on future treatments should therefore take itch into consideration and itch should be evaluated in clinical studies. Among the studied subgroups, Netherton patients experienced the most severe consequences.
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
2095-2100Informations de copyright
© 2019 European Academy of Dermatology and Venereology.
Références
Oji V, Tadini G, Akiyama M et al. Revised nomenclature and classification of inherited ichthyoses: results of the First Ichthyosis Consensus Conference in Sorèze 2009. J Am Acad Dermatol 2010; 63: 607-641.
Hotz A, Bourrat E, Küsel J et al. Mutation update for CYP4F22 variants associated with autosomal recessive congenital ichthyosis. Hum Mutat 2018; 39: 1305-1313.
Haest C, Casaer MP, Daems A et al. Measurement of itching: validation of the Leuven Itch Scale. Burns 2011; 37: 939-950.
Moons P, Casaer MP, Haest C et al. Profile of itch experience in patients with atopic dermatitis, chronic urticaria and burns: direct comparison using the Leuven Itch Scale. Acta Derm Venereol 2011; 91: 631-632.
Snauwaert JJL, Yuen WY, Jonkman MF, Moons P, Naelaers G, Morren MA. Burden of itch in epidermolysis bullosa. Br J Dermatol 2014; 171: 73-78.
World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013; 310: 2191-2194.
Mazereeuw-Hautier J, Dreyfus I, Barbarot S et al. Factors influencing quality of life in patients with inherited ichthyosis: a qualitative study in adults using focus groups. Br J Dermatol 2012; 166: 646-648.
Dreyfus I, Bourrat E, Maruani A et al. Factors associated with impaired quality of life in adult patients suffering from ichthyosis. Acta Derm Venereol 2014; 94: 344-346.
Hernández-Martín A, Dávila-Seijo P, de Lucas R et al. Prioritization of therapy uncertainties in congenital ichthyosis: results from a Priority Setting Partnership. British J Dermatol 2015; 173: 1280-1283.
Paller AS, Renert-Yuval Y, Suprun M et al. An IL-17-dominant immune profile is shared across the major orphan forms of ichthyosis. J Allergy Clin Immunol 2017; 139: 152-165.
Blanchet-Bardon C, Tadini G, Machado Matos M, Delarue A. Association of glycerol and paraffin in the treatment of ichthyosis in children: an international, multicentric, randomized, controlled, double-blind study. J Eur Acad Dermatol Venereol 2012; 26: 1014-1019.
Bodemer C, Bourrat E, Mazereeuw-Hautier J et al. Short- and medium-term efficacy of specific hydrotherapy in inherited ichthyosis. Br J Dermatol 2011; 165: 1087-1094.
Ganemo. Quality of life in Swedish children with congenital ichthyosis. Dermatol Reports 2010; 18: e7.
Vahlquist A, Blockhuys S, Steijlen P et al. Oral liarozole in the treatment of patients with moderate/severe lamellar ichthyosis: results of a randomized, double-blind, multinational, placebo-controlled phase II/III trial. Br J Dermatol 2014; 170: 173-181.
Mazereeuw-Hautier J, Hernandez-Martin A, O'Toole EA et al. Management of congenital ichthyoses: European guidelines of care: part two. Br J Dermatol 2019; 180: 484-495.